MiniMed Group (MMED) director Sandstrom files initial Form 3 ownership
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
MiniMed Group, Inc. director Brian Sandstrom filed an initial Form 3, which is a statement of beneficial ownership for company insiders. This filing lists him as a director of MiniMed Group but does not report any insider stock transactions.
Positive
- None.
Negative
- None.
FAQ
What does the MiniMed Group (MMED) Form 3 filing show?
The Form 3 filing shows that Brian Sandstrom is a director of MiniMed Group, Inc.. It is an initial statement of beneficial ownership and does not report any insider stock transactions in this filing.
Who is the reporting person in MiniMed Group (MMED) Form 3?
The reporting person is Brian Sandstrom, identified as a director of MiniMed Group, Inc.. This status means he is considered an insider and must report his beneficial ownership and future transactions in company securities.
Does the MiniMed Group (MMED) Form 3 show any insider trades?
No insider trades are reported in this Form 3. The transaction summary shows zero buys, zero sells, and no derivative exercises, indicating this filing only establishes insider status without listing transactions.
What is the purpose of a Form 3 for MiniMed Group (MMED) insiders?
Form 3 serves as an initial beneficial ownership statement when someone becomes an insider of MiniMed Group, Inc.. It provides a baseline for future Form 4 and Form 5 reports of trades and other changes in ownership.
Is there any information about derivative securities in the MMED Form 3?
The Form 3 derivative summary for MiniMed Group, Inc. shows no derivative positions or derivative transactions. This indicates no options, warrants, or similar instruments are reported in this particular filing excerpt.